New York, NY -- (SBWIRE) -- 01/20/2014 -- King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Today We bring special trend analysis of following stocks: The Chubb Corporation (NYSE:CB), Zalicus Inc (NASDAQ:ZLCS), Prospect Capital Corporation (NASDAQ:PSEC), Synta Pharmaceuticals Corp. (NASDAQ:SNTA)
PLUS you’ll get KingPennyStock’s Pro Trading Rules Mini E-book absolutely FREE! Claim Your Copy
The Chubb Corporation (NYSE:CB) opened its shares at the price of $90.04 for the day. Its closing price was $89.77 after losing -0.64% for the day. The company traded with the total volume of 2.56 million shares, while its average trading volume remained 1.20 million shares. The beta of CB stands at 0.65. The Chubb Corporation, through its subsidiaries, provides property and casualty insurance to businesses and individuals.
Will CB Get Buyers Even After The Recent Rally? Find Out Here
Zalicus Inc (NASDAQ:ZLCS) percentage change surged +4.94% to close at $1.70 with the total traded volume of 1.89 million shares, and average volume of 1.39 million. The 52 week range of the stock remained $0.88 - $8.28, while its day lowest price was $1.61 and it hit its day highest price at $1.78. Zalicus Inc., a biopharmaceutical company, engages in the discovery and development of novel treatments for patients suffering from pain.
Will ZLCS Continue To Move Higher? Find Out Here
Prospect Capital Corporation (NASDAQ:PSEC) started its trading session with the price of $11.28 and closed at $11.21 by scoring -0.71%. PSEC’s stocks traded with total volume of 2.54 million shares, while the average trading volume remained 2.60 million shares. The beta of PSEC stands at 1.12. Day range of the stock was $11.20 -$11.28. Prospect Capital Corporation is a business development company. It specializes in middle market, mature, mezzanine finance, later stage, emerging growth, buyouts, recapitalizations.
Will PSEC Get Buyers Even After The Recent Rally? Find Out Here
Synta Pharmaceuticals Corp. (NASDAQ:SNTA) ended its day with the loss of -2.68% and closed at the price of $6.17 after opening at $6.35. Stock traded during its last trading session with the total volume of 1.81 million shares, as compared to its average volume of 1.89 million shares. Synta Pharmaceuticals Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs for treating severe medical conditions, including cancer and chronic inflammatory diseases.
Why Should Investors Buy SNTA After the Recent Fall? Just Go Here and Find Out
About King Penny Stocks
King Penny Stocks provides up to the minute dissemination of news while reporting on stocks that are actively traded in the small cap arena whether trading on the Nasdaq small caps, AMEX or the OTC markets. Since performance is key in our industry, it’s no wonder why our ground breaking alerts on active stocks have brought us to the forefront of this industry. Our due diligence on trend analysis has caught the attention of the very best chart technicians in the business.
King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Get detailed breakdowns of major trends impacting the markets.
Our newsletter, Press Release and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company.
An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research. This report/release/advertisement is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation.
Read our Full Disclaimer at: http://kingpennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)